{"id":2234,"date":"2023-01-31T10:59:40","date_gmt":"2023-01-31T09:59:40","guid":{"rendered":"http:\/\/invivo.partners\/2023\/01\/31\/we-are-excited-to-announce-that-claudio-santos-has-joined-us-as-entrepreneur-in-residence-to-support-our-company-creation-activity-in-the-technology-transfer-space\/"},"modified":"2023-02-01T10:55:24","modified_gmt":"2023-02-01T09:55:24","slug":"we-are-excited-to-announce-that-claudio-santos-has-joined-us-as-entrepreneur-in-residence-to-support-our-company-creation-activity-in-the-technology-transfer-space","status":"publish","type":"post","link":"https:\/\/invivo.partners\/ca\/2023\/01\/31\/we-are-excited-to-announce-that-claudio-santos-has-joined-us-as-entrepreneur-in-residence-to-support-our-company-creation-activity-in-the-technology-transfer-space\/","title":{"rendered":"Ens fa molta il\u00b7lusi\u00f3 anunciar que Claudio Santos s’ha unit a nosaltres com a \u00abEntrepreneur in Residence\u00bb per donar suport a la nostra activitat de creaci\u00f3 d’empreses a l’\u00e0mbit de la transfer\u00e8ncia de tecnologia"},"content":{"rendered":"

\"\"<\/h4>\n

Invivo nomena Claudio Santos com a Entrepreneur in Residence<\/em><\/strong><\/span><\/p>\n

Claudio Santos \u00e9s actualment CEO de Gyala i Pulmobiotics, dues empreses de la cartera d’Invivo Ventures<\/strong><\/span><\/p>\n

Barcelona, Espanya, 31 de gener de 2023<\/strong><\/span><\/p>\n

Invivo, una firma espanyola de capital risc que crea i inverteix en empreses que utilitzen la ci\u00e8ncia d’avantguarda per millorar la vida dels pacients, ha anunciat avui el nomenament de Claudio Santos, PhD com a Entrepreneur in Residence<\/em> (EIR). Donar\u00e0 suport a les activitats d’Invivo a diferents nivells, incloent la cerca de noves oportunitats d\u2019inversi\u00f3, la due diligence<\/em> d\u2019aquestes i la gesti\u00f3 a nivell executiu de les empreses de nova creaci\u00f3.<\/p>\n

El Dr. Santos aporta una \u00e0mplia formaci\u00f3 en recerca biom\u00e8dica, transfer\u00e8ncia de tecnologia, capital risc i gesti\u00f3 d’empreses biotecnol\u00f2giques. \u00c9s, i seguir\u00e0 sent, el CEO de dues empreses de la cartera d’Invivo Ventures: Gyala Therapeutics, una spin-off de l’Hospital Cl\u00ednic de Barcelona que desenvolupa una ter\u00e0pia cel\u00b7lular CAR-T contra una nova diana per combatre les neopl\u00e0sies hematol\u00f2giques; i Pulmobiotics, una empresa de biologia sint\u00e8tica que utilitza la tecnologia desenvolupada per Luis Serrano i Maria Lluch al CRG per desenvolupar \u201cp\u00edndoles vives\u201d per al tractament de malalties pulmonars.<\/p>\n

Comentant el seu nomenament, Claudio va dir: \u00abEstic molt content d’unir-me a Invivo en un moment tan emocionant per a la firma i l’entorn biotecnol\u00f2gic a Espanya. La traject\u00f2ria d’Invivo \u00e9s impressionant, amb diverses empreses del seu primer fons recentment signant acords de llic\u00e8ncia o adquisici\u00f3. En el futur, el seu enfocament en la transfer\u00e8ncia de tecnologia i la creaci\u00f3 d’empreses en l\u2019\u00e0mbit de les ter\u00e0pies avan\u00e7ades i de la biologia sint\u00e8tica, aix\u00ed com la seva creen\u00e7a que la cerca del benefici del pacient hauria de guiar totes les decisions preses, s’alinea amb el meu punt de vista i perspectives sobre el camp\u00bb.<\/p>\n

Abans d’assumir el c\u00e0rrec de CEO a Gyala i Pulmobiotics, Claudio va treballar com a consultor independent d’empreses biotecnol\u00f2giques i fons de capital risc, com a Director de Negoci a Highlight Therapeutics i com a Director de Planificaci\u00f3 Estrat\u00e8gica a AdorX Therapeutics (empresa que va signar una col\u00b7laboraci\u00f3 estrat\u00e8gica amb J&J el 2019). Abans, va ser Associat al CRT Pioneer Fund (Regne Unit), on va dirigir inversions a Achilles Therapeutics, Artios Pharma, Neophore Ltd i el \u00abPrograma d’inhibidors de Ras\u00bb (en col\u00b7laboraci\u00f3 amb Novartis) i Gestor de transfer\u00e8ncia de tecnologia al Cancer Research Technology, contribuint a acords de llic\u00e8ncia amb MSD i BioInvent AB.<\/p>\n

\u00abVam comen\u00e7ar a treballar amb el Claudio el 2020 com a part del nostre comprom\u00eds de donar suport a les empreses de cartera ajudant-les a contractar perfils per a posicions executives, aix\u00ed com a nivell de Consell d\u2019Administraci\u00f3 i Scientific Advisory Board<\/em>\u00ab, va dir el Dr. Luis Pareras, soci director d’Invivo. \u00abCreiem que la seva experi\u00e8ncia en diferents rols en tot l’ecosistema d’innovaci\u00f3 biotecnol\u00f2gica ser\u00e0 un actiu per a Invivo, a mesura que avancem realitzant noves inversions i donant-les suport\u00bb.<\/p>\n

Sobre Invivo<\/strong>
\nnvivo \u00e9s una firma espanyola de capital risc fundada pel Dr. Luis Pareras i Albert Ferrer amb m\u00e9s de 70M\u20ac sota gesti\u00f3 a trav\u00e9s dels seus fons Healthequity i Invivo Ventures. Invivo Ventures FCR compta amb una majoria d’inversors privats, i amb el suport d’inversors institucionals com el Fons Europeu d’Inversions (FEI), Fond-ICO Global, l’Institut Catal\u00e0 de Finances, l’Institut Valenci\u00e0 de Finances i l’Ajuntament de Barcelona.<\/p>\n

Descarrega PDF<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Invivo nomena Claudio Santos com a Entrepreneur in Residence Claudio Santos \u00e9s actualment CEO de Gyala i Pulmobiotics, dues empreses de la cartera d’Invivo Ventures Barcelona, Espanya, 31 de gener de 2023 Invivo, una firma espanyola de capital risc que crea i inverteix en empreses que utilitzen la ci\u00e8ncia d’avantguarda per millorar la vida dels<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[516],"tags":[],"class_list":["post-2234","post","type-post","status-publish","format-standard","hentry","category-noticias-ca"],"acf":[],"yoast_head":"\nEns fa molta il\u00b7lusi\u00f3 anunciar que Claudio Santos s'ha unit a nosaltres com a "Entrepreneur in Residence" per donar suport a la nostra activitat de creaci\u00f3 d'empreses a l'\u00e0mbit de la transfer\u00e8ncia de tecnologia - Invivo Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/invivo.partners\/ca\/2023\/01\/31\/we-are-excited-to-announce-that-claudio-santos-has-joined-us-as-entrepreneur-in-residence-to-support-our-company-creation-activity-in-the-technology-transfer-space\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ens fa molta il\u00b7lusi\u00f3 anunciar que Claudio Santos s'ha unit a nosaltres com a "Entrepreneur in Residence" per donar suport a la nostra activitat de creaci\u00f3 d'empreses a l'\u00e0mbit de la transfer\u00e8ncia de tecnologia - Invivo Partners\" \/>\n<meta property=\"og:description\" content=\"Invivo nomena Claudio Santos com a Entrepreneur in Residence Claudio Santos \u00e9s actualment CEO de Gyala i Pulmobiotics, dues empreses de la cartera d’Invivo Ventures Barcelona, Espanya, 31 de gener de 2023 Invivo, una firma espanyola de capital risc que crea i inverteix en empreses que utilitzen la ci\u00e8ncia d’avantguarda per millorar la vida dels\" \/>\n<meta property=\"og:url\" content=\"https:\/\/invivo.partners\/ca\/2023\/01\/31\/we-are-excited-to-announce-that-claudio-santos-has-joined-us-as-entrepreneur-in-residence-to-support-our-company-creation-activity-in-the-technology-transfer-space\/\" \/>\n<meta property=\"og:site_name\" content=\"Invivo Partners\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-31T09:59:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-02-01T09:55:24+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/invivo.partners\/wp-content\/uploads\/2023\/01\/Claudio-Santos_web-300x300.jpg\" \/>\n<meta name=\"author\" content=\"invivo\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"invivo\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/invivo.partners\/ca\/2023\/01\/31\/we-are-excited-to-announce-that-claudio-santos-has-joined-us-as-entrepreneur-in-residence-to-support-our-company-creation-activity-in-the-technology-transfer-space\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/invivo.partners\/ca\/2023\/01\/31\/we-are-excited-to-announce-that-claudio-santos-has-joined-us-as-entrepreneur-in-residence-to-support-our-company-creation-activity-in-the-technology-transfer-space\/\"},\"author\":{\"name\":\"invivo\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/person\/f382d91fa1fbbe4bb94f3093438e5789\"},\"headline\":\"Ens fa molta il\u00b7lusi\u00f3 anunciar que Claudio Santos s’ha unit a nosaltres com a \u00abEntrepreneur in Residence\u00bb per donar suport a la nostra activitat de creaci\u00f3 d’empreses a l’\u00e0mbit de la transfer\u00e8ncia de tecnologia\",\"datePublished\":\"2023-01-31T09:59:40+00:00\",\"dateModified\":\"2023-02-01T09:55:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/invivo.partners\/ca\/2023\/01\/31\/we-are-excited-to-announce-that-claudio-santos-has-joined-us-as-entrepreneur-in-residence-to-support-our-company-creation-activity-in-the-technology-transfer-space\/\"},\"wordCount\":644,\"publisher\":{\"@id\":\"https:\/\/invivo.partners\/#organization\"},\"articleSection\":[\"Noticias\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/invivo.partners\/ca\/2023\/01\/31\/we-are-excited-to-announce-that-claudio-santos-has-joined-us-as-entrepreneur-in-residence-to-support-our-company-creation-activity-in-the-technology-transfer-space\/\",\"url\":\"https:\/\/invivo.partners\/ca\/2023\/01\/31\/we-are-excited-to-announce-that-claudio-santos-has-joined-us-as-entrepreneur-in-residence-to-support-our-company-creation-activity-in-the-technology-transfer-space\/\",\"name\":\"Ens fa molta il\u00b7lusi\u00f3 anunciar que Claudio Santos s'ha unit a nosaltres com a \\\"Entrepreneur in Residence\\\" per donar suport a la nostra activitat de creaci\u00f3 d'empreses a l'\u00e0mbit de la transfer\u00e8ncia de tecnologia - Invivo Partners\",\"isPartOf\":{\"@id\":\"https:\/\/invivo.partners\/#website\"},\"datePublished\":\"2023-01-31T09:59:40+00:00\",\"dateModified\":\"2023-02-01T09:55:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/invivo.partners\/ca\/2023\/01\/31\/we-are-excited-to-announce-that-claudio-santos-has-joined-us-as-entrepreneur-in-residence-to-support-our-company-creation-activity-in-the-technology-transfer-space\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/invivo.partners\/ca\/2023\/01\/31\/we-are-excited-to-announce-that-claudio-santos-has-joined-us-as-entrepreneur-in-residence-to-support-our-company-creation-activity-in-the-technology-transfer-space\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/invivo.partners\/ca\/2023\/01\/31\/we-are-excited-to-announce-that-claudio-santos-has-joined-us-as-entrepreneur-in-residence-to-support-our-company-creation-activity-in-the-technology-transfer-space\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/invivo.partners\/ca\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ens fa molta il\u00b7lusi\u00f3 anunciar que Claudio Santos s’ha unit a nosaltres com a “Entrepreneur in Residence” per donar suport a la nostra activitat de creaci\u00f3 d’empreses a l’\u00e0mbit de la transfer\u00e8ncia de tecnologia\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/invivo.partners\/#website\",\"url\":\"https:\/\/invivo.partners\/\",\"name\":\"Invivo Capital\",\"description\":\"Somos un fondo de capital riesgo especializado en proyectos early-stage del sector salud.\",\"publisher\":{\"@id\":\"https:\/\/invivo.partners\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/invivo.partners\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/invivo.partners\/#organization\",\"name\":\"Invivo Capital\",\"url\":\"https:\/\/invivo.partners\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg\",\"contentUrl\":\"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg\",\"width\":1200,\"height\":630,\"caption\":\"Invivo Capital\"},\"image\":{\"@id\":\"https:\/\/invivo.partners\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/person\/f382d91fa1fbbe4bb94f3093438e5789\",\"name\":\"invivo\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/3c1e935daee28cd9cccdda9f9bb7f784c23881fa1325206e7c53c9119500139c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/3c1e935daee28cd9cccdda9f9bb7f784c23881fa1325206e7c53c9119500139c?s=96&d=mm&r=g\",\"caption\":\"invivo\"},\"url\":\"https:\/\/invivo.partners\/ca\/author\/invivocapital\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ens fa molta il\u00b7lusi\u00f3 anunciar que Claudio Santos s'ha unit a nosaltres com a \"Entrepreneur in Residence\" per donar suport a la nostra activitat de creaci\u00f3 d'empreses a l'\u00e0mbit de la transfer\u00e8ncia de tecnologia - Invivo Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/invivo.partners\/ca\/2023\/01\/31\/we-are-excited-to-announce-that-claudio-santos-has-joined-us-as-entrepreneur-in-residence-to-support-our-company-creation-activity-in-the-technology-transfer-space\/","og_locale":"ca_ES","og_type":"article","og_title":"Ens fa molta il\u00b7lusi\u00f3 anunciar que Claudio Santos s'ha unit a nosaltres com a \"Entrepreneur in Residence\" per donar suport a la nostra activitat de creaci\u00f3 d'empreses a l'\u00e0mbit de la transfer\u00e8ncia de tecnologia - Invivo Partners","og_description":"Invivo nomena Claudio Santos com a Entrepreneur in Residence Claudio Santos \u00e9s actualment CEO de Gyala i Pulmobiotics, dues empreses de la cartera d’Invivo Ventures Barcelona, Espanya, 31 de gener de 2023 Invivo, una firma espanyola de capital risc que crea i inverteix en empreses que utilitzen la ci\u00e8ncia d’avantguarda per millorar la vida dels","og_url":"https:\/\/invivo.partners\/ca\/2023\/01\/31\/we-are-excited-to-announce-that-claudio-santos-has-joined-us-as-entrepreneur-in-residence-to-support-our-company-creation-activity-in-the-technology-transfer-space\/","og_site_name":"Invivo Partners","article_published_time":"2023-01-31T09:59:40+00:00","article_modified_time":"2023-02-01T09:55:24+00:00","og_image":[{"url":"http:\/\/invivo.partners\/wp-content\/uploads\/2023\/01\/Claudio-Santos_web-300x300.jpg"}],"author":"invivo","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"invivo","Temps estimat de lectura":"3 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/invivo.partners\/ca\/2023\/01\/31\/we-are-excited-to-announce-that-claudio-santos-has-joined-us-as-entrepreneur-in-residence-to-support-our-company-creation-activity-in-the-technology-transfer-space\/#article","isPartOf":{"@id":"https:\/\/invivo.partners\/ca\/2023\/01\/31\/we-are-excited-to-announce-that-claudio-santos-has-joined-us-as-entrepreneur-in-residence-to-support-our-company-creation-activity-in-the-technology-transfer-space\/"},"author":{"name":"invivo","@id":"https:\/\/invivo.partners\/#\/schema\/person\/f382d91fa1fbbe4bb94f3093438e5789"},"headline":"Ens fa molta il\u00b7lusi\u00f3 anunciar que Claudio Santos s’ha unit a nosaltres com a \u00abEntrepreneur in Residence\u00bb per donar suport a la nostra activitat de creaci\u00f3 d’empreses a l’\u00e0mbit de la transfer\u00e8ncia de tecnologia","datePublished":"2023-01-31T09:59:40+00:00","dateModified":"2023-02-01T09:55:24+00:00","mainEntityOfPage":{"@id":"https:\/\/invivo.partners\/ca\/2023\/01\/31\/we-are-excited-to-announce-that-claudio-santos-has-joined-us-as-entrepreneur-in-residence-to-support-our-company-creation-activity-in-the-technology-transfer-space\/"},"wordCount":644,"publisher":{"@id":"https:\/\/invivo.partners\/#organization"},"articleSection":["Noticias"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/invivo.partners\/ca\/2023\/01\/31\/we-are-excited-to-announce-that-claudio-santos-has-joined-us-as-entrepreneur-in-residence-to-support-our-company-creation-activity-in-the-technology-transfer-space\/","url":"https:\/\/invivo.partners\/ca\/2023\/01\/31\/we-are-excited-to-announce-that-claudio-santos-has-joined-us-as-entrepreneur-in-residence-to-support-our-company-creation-activity-in-the-technology-transfer-space\/","name":"Ens fa molta il\u00b7lusi\u00f3 anunciar que Claudio Santos s'ha unit a nosaltres com a \"Entrepreneur in Residence\" per donar suport a la nostra activitat de creaci\u00f3 d'empreses a l'\u00e0mbit de la transfer\u00e8ncia de tecnologia - Invivo Partners","isPartOf":{"@id":"https:\/\/invivo.partners\/#website"},"datePublished":"2023-01-31T09:59:40+00:00","dateModified":"2023-02-01T09:55:24+00:00","breadcrumb":{"@id":"https:\/\/invivo.partners\/ca\/2023\/01\/31\/we-are-excited-to-announce-that-claudio-santos-has-joined-us-as-entrepreneur-in-residence-to-support-our-company-creation-activity-in-the-technology-transfer-space\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/invivo.partners\/ca\/2023\/01\/31\/we-are-excited-to-announce-that-claudio-santos-has-joined-us-as-entrepreneur-in-residence-to-support-our-company-creation-activity-in-the-technology-transfer-space\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/invivo.partners\/ca\/2023\/01\/31\/we-are-excited-to-announce-that-claudio-santos-has-joined-us-as-entrepreneur-in-residence-to-support-our-company-creation-activity-in-the-technology-transfer-space\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/invivo.partners\/ca\/"},{"@type":"ListItem","position":2,"name":"Ens fa molta il\u00b7lusi\u00f3 anunciar que Claudio Santos s’ha unit a nosaltres com a “Entrepreneur in Residence” per donar suport a la nostra activitat de creaci\u00f3 d’empreses a l’\u00e0mbit de la transfer\u00e8ncia de tecnologia"}]},{"@type":"WebSite","@id":"https:\/\/invivo.partners\/#website","url":"https:\/\/invivo.partners\/","name":"Invivo Capital","description":"Somos un fondo de capital riesgo especializado en proyectos early-stage del sector salud.","publisher":{"@id":"https:\/\/invivo.partners\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/invivo.partners\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/invivo.partners\/#organization","name":"Invivo Capital","url":"https:\/\/invivo.partners\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/invivo.partners\/#\/schema\/logo\/image\/","url":"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg","contentUrl":"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg","width":1200,"height":630,"caption":"Invivo Capital"},"image":{"@id":"https:\/\/invivo.partners\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/invivo.partners\/#\/schema\/person\/f382d91fa1fbbe4bb94f3093438e5789","name":"invivo","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/invivo.partners\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/3c1e935daee28cd9cccdda9f9bb7f784c23881fa1325206e7c53c9119500139c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3c1e935daee28cd9cccdda9f9bb7f784c23881fa1325206e7c53c9119500139c?s=96&d=mm&r=g","caption":"invivo"},"url":"https:\/\/invivo.partners\/ca\/author\/invivocapital\/"}]}},"_links":{"self":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/posts\/2234","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/comments?post=2234"}],"version-history":[{"count":14,"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/posts\/2234\/revisions"}],"predecessor-version":[{"id":2293,"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/posts\/2234\/revisions\/2293"}],"wp:attachment":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/media?parent=2234"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/categories?post=2234"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/tags?post=2234"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}